Once a vaccine is granted emergency approval, there is pressure to offer immunization to trial participants who received placebo. But if too many people cross over to vaccine group, companies might not have enough data to establish long-term outcomes,
nature.com/articles/d4158… https://t.co/UmW33iCr3l
Dallas Fed reports that regional manufacturers see price pressures and supply bottlenecks easing. @SoberLook thedailyshot.com/2022/06/28/bus… https://t.co/70Shm4Vc18
June 28, 2022
Dallas Fed reports that regional manufacturers see price pressures and supply bottlenecks easing. @SoberLook thedailyshot.com/2022/06/28/bus… https://t.co/70Shm4Vc18